Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Cardiac Failure

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Cardiac Failure in 4 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Research Excerpts

ExcerptRelevanceReference
" β2-adrenergic, M2-muscarinic and A1-adenosine receptors) that are responsible for these abnormalities in heart failure by chronically administrating mice a selective antagonist of each receptor (ICI118,551, atropine and 8-cyclopentyl-1,3-dipropilxanthine (DPCPX), respectively) with isoproterenol."3.80β(2)-Adrenergic and M(2)-muscarinic receptors decrease basal t-tubular L-type Ca2+ channel activity and suppress ventricular contractility in heart failure. ( Gomi, S; Hirose, M; Hongo, M; Kashihara, T; Nakada, T; Shimojo, H; Yamada, M, 2014)
"Cl and milrinone at A1 adenosine receptors and m-cholinoceptors were evaluated in human myocardium from patients with heart failure."3.68Antagonism of novel inotropic agents at A1 adenosine receptors and m-cholinoceptors in human myocardium. ( Böhm, M; Erdmann, E; Schwinger, RH; Ungerer, M, 1990)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Long, VP1
Bonilla, IM1
Baine, S1
Glynn, P1
Kumar, S1
Schober, K1
Mowrey, K1
Weiss, R2
Lee, NY1
Mohler, PJ2
Györke, S2
Hund, TJ1
Fedorov, VV2
Carnes, CA2
Kashihara, T1
Hirose, M1
Shimojo, H1
Nakada, T1
Gomi, S1
Hongo, M1
Yamada, M1
Lou, Q1
Hansen, BJ1
Fedorenko, O1
Csepe, TA1
Kalyanasundaram, A1
Li, N1
Hage, LT1
Glukhov, AV1
Billman, GE1
Biesiadecki, BJ1
Ungerer, M1
Böhm, M1
Schwinger, RH1
Erdmann, E1

Other Studies

4 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Cardiac Failure

ArticleYear
Chronic heart failure increases negative chronotropic effects of adenosine in canine sinoatrial cells via A1R stimulation and GIRK-mediated I
    Life sciences, 2020, Jan-01, Volume: 240

    Topics: Action Potentials; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Ani

2020
β(2)-Adrenergic and M(2)-muscarinic receptors decrease basal t-tubular L-type Ca2+ channel activity and suppress ventricular contractility in heart failure.
    European journal of pharmacology, 2014, Feb-05, Volume: 724

    Topics: Adenosine A1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atropine; Calcium Channels,

2014
Upregulation of adenosine A1 receptors facilitates sinoatrial node dysfunction in chronic canine heart failure by exacerbating nodal conduction abnormalities revealed by novel dual-sided intramural optical mapping.
    Circulation, 2014, Jul-22, Volume: 130, Issue:4

    Topics: Action Potentials; Adenosine; Adenosine A1 Receptor Antagonists; Animals; Atrial Fibrillation; Brady

2014
Antagonism of novel inotropic agents at A1 adenosine receptors and m-cholinoceptors in human myocardium.
    Naunyn-Schmiedeberg's archives of pharmacology, 1990, Volume: 341, Issue:6

    Topics: Adult; Binding, Competitive; Cardiotonic Agents; Electric Stimulation; Guanylyl Imidodiphosphate; He

1990